Biomarin Pharmaceutical Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biomarin Pharmaceutical Inc's ROI in the third quarter of 2026?
Biomarin Pharmaceutical Inc recorded a cumulative net loss of $-19 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -0.21%.

Within the Healthcare sector 180 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1671 to 1762.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Investment Change TTM	34.28 %	23.82 %	12.72 %	10.86 %	12.32 %
Y / Y Net Income Change TTM	-	-88.9 %	-35.51 %	51.02 %	390.59 %
Investment (TTM) in Millions	10,430	10,508	7,798	6,835	6,816
Return On Investment (TTM)	-0.21 %	0.91 %	3.81 %	5.18 %	7.86 %
BMRN's Overall Ranking	# 1762	# 1671	# 988	# 394	#
Seq. Investment Change TTM	11.31 %	13.24 %	4.75 %	1.71 %	2.64 %
Seq. Net Income Change TTM	-	-72.85 %	-22.97 %	-32.96 %	-20.82 %
Net Income (TTM) in Millions	-19	73	269	349	520

BMRN Company Profile >> Back to BMRN Roi Comparisons >> See Annual BMRN Return On Investment

Return On Investment BMRN's Ranking
Within:	No.
Industry	# 61
Sector	# 181
Overall	# 1762

Return On Investment Statistics
High	Average	Low
21.79 %	-0.5 %	-18.95 %
(Mar 31 2011)		(Dec 31 2016)

Financial Statements
Biomarin Pharmaceutical Inc's III. Quarter Investments	$ 10,430 Millions	BMRN's Balance sheet
Biomarin Pharmaceutical Inc's III. Quarter Income	$ -123 Millions	Quarterly BMRN's Income Statement
BMRN's Income by Division		See BMRN's Income by Division

BMRN Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	6,835	6,382	5,665	5,786	5,464
Y / Y Investment Growth	7.1 %	12.66 %	-2.1 %	5.91 %	2.02 %
Net Income in Millions	349	427	168	142	-64
Y / Y Net Income Growth	-18.26 %	154.62 %	18.43 %	-	-
Annual Return On Investment	5.1 %	6.69 %	2.96 %	2.45 %	-1.17 %

Annual Roi Comment

In the fiscal year 2025 ROI decreased relative to the previous year to 5.1 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BMRN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BMRN's Competitors
Subscribers only: Roi for Biomarin Pharmaceutical Inc's Suppliers
Subscribers only: Return On Investment for BMRN's Customers

Other Ratios
BMRN's Roa	BMRN's Inventory Turnover Ratio	BMRN's Growth Rates	BMRN's Dividend Statistics
	BMRN's Profitability Ratios	BMRN's Asset Turnover Ratio	BMRN's Dividend Growth
BMRN's Roe	BMRN's Valuation Ratios	BMRN's Financial Strength Ratios	BMRN's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector

ROI

Date modified: 2026-11-05T14:33:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.